These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 8645628

  • 1. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A, Allegrini PR, Biollaz M, Batzl C, Scheidegger E, Bhatnagar AS.
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [Abstract] [Full Text] [Related]

  • 2. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
    di Salle E, Giudici D, Radice A, Zaccheo T, Ornati G, Nesi M, Panzeri A, Délos S, Martin PM.
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412
    [Abstract] [Full Text] [Related]

  • 3. Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.
    di Salle E, Giudici D, Briatico G, Ornati G, Panzeri A.
    J Steroid Biochem Mol Biol; 1993 Nov; 46(5):549-55. PubMed ID: 8240976
    [Abstract] [Full Text] [Related]

  • 4. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
    Di Salle E, Briatico G, Giudici D, Ornati G, Panzeri A.
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS, Cai X, Abasolo I, Wang Z.
    Gene Expr; 2001 Feb; 9(4-5):183-94. PubMed ID: 11444528
    [Abstract] [Full Text] [Related]

  • 6. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS.
    Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
    [Abstract] [Full Text] [Related]

  • 7. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
    Nnane IP, Kato K, Liu Y, Lu Q, Wang X, Ling YZ, Brodie A.
    Cancer Res; 1998 Sep 01; 58(17):3826-32. PubMed ID: 9731491
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaughan ED.
    Endocrinology; 1992 Sep 01; 131(3):1149-56. PubMed ID: 1324152
    [Abstract] [Full Text] [Related]

  • 9. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF, Yang Y, Wang W, Qiu Z, Zhang P, Wang B.
    Chin Med J (Engl); 2013 Feb 01; 126(4):711-5. PubMed ID: 23422194
    [Abstract] [Full Text] [Related]

  • 10. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G, Rittmaster RS, Klocker H.
    Eur Urol; 2000 Apr 01; 37(4):367-80. PubMed ID: 10765065
    [Abstract] [Full Text] [Related]

  • 11. Central 5-alpha reduction of testosterone is required for testosterone's inhibition of the hypothalamo-pituitary-adrenal axis response to restraint stress in adult male rats.
    Handa RJ, Kudwa AE, Donner NC, McGivern RF, Brown R.
    Brain Res; 2013 Sep 05; 1529():74-82. PubMed ID: 23880372
    [Abstract] [Full Text] [Related]

  • 12. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C, Varela C, Correia-da-Silva G, Tavares da Silva E, Carvalho RA, Costa SC, Cunha SC, Fernandes JO, Teixeira N, Roleira FM.
    Biochimie; 2013 Nov 05; 95(11):2097-106. PubMed ID: 23933094
    [Abstract] [Full Text] [Related]

  • 13. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW.
    Endocrinology; 1997 Mar 05; 138(3):871-7. PubMed ID: 9048585
    [Abstract] [Full Text] [Related]

  • 14. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
    Yasuda N, Fujino K, Shiraji T, Nambu F, Kondo K.
    Jpn J Pharmacol; 1997 Jul 05; 74(3):243-52. PubMed ID: 9268084
    [Abstract] [Full Text] [Related]

  • 15. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
    Pérez-Ornelas V, Cabeza M, Bratoeff E, Heuze I, Sánchez M, Ramírez E, Naranjo-Rodríguez E.
    Steroids; 2005 Mar 05; 70(3):217-24. PubMed ID: 15763601
    [Abstract] [Full Text] [Related]

  • 16. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects.
    Giudici D, Briatico G, Cominato C, Zaccheo T, Iehlè C, Nesi M, Panzeri A, di Salle E.
    J Steroid Biochem Mol Biol; 1996 Jun 05; 58(3):299-305. PubMed ID: 8836165
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W, Kearbey JD, Nair VA, Chung K, Parlow AF, Miller DD, Dalton JT.
    Endocrinology; 2004 Dec 05; 145(12):5420-8. PubMed ID: 15308613
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
    Cohen SM, Werrmann JG, Rasmusson GH, Tanaka WK, Malatesta PF, Prahalada S, Jacobs JG, Harris G, Nett TM.
    Prostate; 1995 Feb 05; 26(2):55-71. PubMed ID: 7531846
    [Abstract] [Full Text] [Related]

  • 19. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS.
    J Clin Invest; 1996 Dec 01; 98(11):2558-63. PubMed ID: 8958218
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M, Diffley P, Stephen G, Price D, Walton TJ, Newton RP.
    Life Sci; 2002 May 31; 71(2):115-26. PubMed ID: 12031682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.